Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-105
Closed -$4.81K 839
2024
Q4
$4.81K Sell
105
-2
-2% -$90 ﹤0.01% 738
2024
Q3
$5.01K Buy
107
+4
+4% +$182 ﹤0.01% 737
2024
Q2
$4.36K Buy
+103
New +$4.52K ﹤0.01% 757
2024
Q1
Sell
-77
Closed -$3.56K 870
2023
Q4
$3.56K Buy
+77
New +$3.27K ﹤0.01% 747

Other funds holding QGEN

Washington Trust's QGEN Position: Q1 2025 in Review

Washington Trust sold out of Qiagen (QGEN) in Q1 2025, closing a stake of 105 shares — an estimated $4.81K sold.

Washington Trust first reported a position in QGEN in Q4 2023 and held it in 4 quarters. The position peaked at $5.01K in Q3 2024. 298 funds tracked by Wall St. Rank hold QGEN as of Q1 2025.

  • Washington Trust reported no remaining Qiagen position as of Q1 2025 after selling out during the quarter.
  • Washington Trust sold 105 Qiagen shares in Q1 2025, an estimated $4.81K.
  • Washington Trust first reported a position in Qiagen in Q4 2023 and held it in 4 quarters.
  • Washington Trust's Qiagen position peaked at $5.01K in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Qiagen as of Q1 2025.

Based on Washington Trust's 13F filing for Q1 2025, filed 25 Apr 2025.